Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Understanding who benefits most from opening a Roth IRA helps you decide if this account fits your retirement strategy and tax outlook.
23,663 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Analysts publish a broad slate of Wednesday notes, highlighting opportunities across metals, energy, consumer staples...
A high-profile fund manager dumped a huge chunk of AMD stock in one day. The move sparked questions about portfolio s...
Dave Ramsey renews warnings against raiding retirement savings to pay debt. This report explains the costs and lays o...
California is backing electric vehicle buyers with a new point-of-sale rebate program. For Rivian, this policy shift ...
Small-cap exposure is a cornerstone of growth for many investors. This article compares Schwab SCHA and iShares IJR, ...
A Brooklyn rehab clinic case has public officials chasing a suspected scam spanning years. This article breaks down w...
As 2026 unfolds, investors face a choice between StubHub's fast-growing digital ticketing platform and Build-A-Bear's...
A proposed bill would end the Social Security earnings test for those under full retirement age, potentially increasi...
Investors watched the latest inflation data closely as Warsh took the helm. This article explains why softer inflatio...
SpaceX is the darling of space dreams and bold tech bets. This article breaks down what it would take for a public Sp...
Investors are watching the S&P 500 with caution. A high CAPE reading can signal long-term risks, but smart planning—s...